Ignite Creation Date:
2025-12-24 @ 10:53 PM
Ignite Modification Date:
2026-05-19 @ 12:49 AM
Study NCT ID:
NCT01662869
Status:
COMPLETED
Last Update Posted:
2016-11-02
First Post:
2012-08-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Onartuzumab in Combination With mFOLFOX6 in Participants With Metastatic HER2-Negative and MET-Positive Gastroesophageal Cancer
Sponsor:
Hoffmann-La Roche
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Gastric Cancer | View |
Keywords: